German Observational Multicenter Study of Patients With Fabry Disease Under Chaperone Therapy With Migalastat-HCl.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Sep 2018
At a glance
- Drugs Migalastat (Primary)
- Indications Fabry's disease
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2017 Status changed from not yet recruiting to recruiting.